Sobre Candel - Visión y Equipo

Transformando el Acceso a Neuromodulación en Latinoamérica

Misión: Hacer la neuroestimulación domiciliaria accesible, segura y efectiva para cada paciente que la necesite.

Por qué Candel?

La tDCS es clínicamente validada hace más de 15 años. Pero sigue siendo inaccesible para la mayoría: requiere entrenamiento especializado, es cara, y casi nunca está disponible en centros públicos.

Candel resuelve esto diseñando para:

  • Accesibilidad radical: Dispositivo que adultos mayores pueden usar sin entrenamiento técnico
  • Plataforma integrada: Hardware + software + protocolos médicos en un ecosistema único
  • Modelo sostenible: B2B con centros clínicos + DaaS recurrente + venta directa al paciente

Validación Clínica

  • 200+ pacientes en tratamiento activo
  • 11 hospitales y centros clínicos activos en Chile
  • Non-inferiority trial vs. Soterix Medical (feb 2023) ✓ POSITIVO
  • Ensayos ACV en Hospital Clínico U. Chile (80+ pacientes)
  • Ensayos TEC en Mutual de Seguridad (50+ pacientes)

Premios y Reconocimientos

  • 🏆 1er Lugar BRAIN Chile UC-Santander 2023
  • 🏆 Human Health Award Big Bang! UC Davis 2024 (USD 12.500)
  • 🏆 Ganador StartUp Ciencia 2024 ANID-CORFO
  • 🏆 1er Lugar PLASMA 2026 Aggie Square UC Davis
  • 🏆 Única empresa chilena en UC Berkeley Skydeck (PAD-13)

Equipo Fundador

Raúl Castillo - CEO & Co-founder
Médico Cirujano U. Chile · PhD(c) Ingeniería Biomédica, UC Davis · Campeón Nacional de Programación · Experiencia en neuromodulación clínica

Sebastián Muena - CFO/COO & Co-founder
Ingeniero Comercial U. Chile · Ex DiDi (pre-IPO) · Experiencia en scaling y operaciones

Lucía Del Valle - CMO & Co-founder
Médica Cirujana U. Chile · PhD(c) Neurología · Nobel Laureate Fellow

Asesores Científicos

Prof. Dr. Nigel Pedersen - Associate Professor Neurology, UC Davis
Prof. Dr. Rómulo Fuentes - Director de Investigación, Facultad de Medicina U. Chile
Prof. Dr. José Manuel Matamala - Neurólogo, Clínica Alemana

Únete a Nosotros

Estamos buscando:

  • Especialistas en neurología interesados en telemedicina
  • Equipos comerciales con experiencia en salud
  • Investigadores en neuromodulación

Envíanos tu CV

Best-selling

What is tDCS?

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation (NIBS) technique. It is based on the controlled application of a low-intensity electrical current, vibrating between 1 and 2 milliamperes (mA), through the placement of two electrodes, one anodal and one cathodal, on the surface of the brain. tDCS is an emerging therapy for neurological conditions.

Scientific evidence of tDCS

Combined therapy of bilateral transcranial direct current stimulation and ocular occlusion improves visual function in adults with amblyopia, a randomized pilot study

 More information here

The effects of transcranial direct-current stimulation (tDCS) on pain intensity of patients with fibromyalgia: a systematic review and meta-analysis

 More information here

Early transcranial direct current stimulation with modified constraint-induced movement therapy for motor and functional upper limb recovery in hospitalized patients with stroke: A randomized, multicentre, double-blind, clinical trial.

 More information here

Our commitment to patient well-being

At Candel, we are dedicated to providing safe and quality rehabilitation, accessible to all. With cutting-edge medical technology, we work tirelessly to develop innovations that will improve the future of neurology, ensuring that every patient receives the best possible care.

We are on Mercado Público!

We are the only national company that commercializes neurostimulators in Mercado Público, facilitating access to advanced technology for neurological rehabilitation.

OUR

SPECIALISTS

Raúl Castillo

Physician from the University of Chile. PhD candidate in Biomedical Engineering at the University of California, Davis. Founder and CEO.

Lucía Del Valle

MD from the University of Chile. PhD candidate in Medical Sciences and specialist in Neurology from the University of Chile. Co-founder and CSO.

OUR ADVISORS

Prof. Dr. Nigel Pedersen

Neurologist and Epileptologist. Associate Professor and Director of Research, Department of Neurology, UC Davis. Scientific and Medical Advisor.

Prof. Dr. Rómulo Fuentes Flores

Mentor and Technical-Scientific Advisor. Director of Research at the Faculty of Medicine, University of Chile.

Prof. Dr. José Manuel Matamala

Neurologist at Clínica Alemana - PhD in Medical Sciences. Scientific and Medical Advisor.
crea una imagen de invvestigadores/neurologos

FOR RESEARCHERS

At Candel Medical Company, we support the development of clinical and scientific research in neuromodulation technologies.

Our Researchers Program is designed to facilitate access to technology, offer preferential conditions, and support projects seeking to generate evidence and advance innovation in healthcare.

If you are conducting research or have a project in the planning stage, we would like to hear from you.

Contact us at: contacto@candelmed.cl

Subject: Researchers Program